Evidence map›Paper›PMID 35767654›Full record

ArticleScience translational medicine2022

MECP2-related pathways are dysregulated in a cortical organoid model of myotonic dystrophy.

Kathryn H Morelli, Wenhao Jin, Shashank Shathe, Assael A Madrigal, Krysten L Jones, Joshua L Schwartz, Tristan Bridges, Jasmine R Mueller, Archana Shankar, Isaac A Chaim and 2 more

Open access · greenAbstract read
In one paragraph

Article in Science translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Understanding Glioblastoma Dynamics Using 3D Organoids and Engineered Extracellular Matrix.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  10. Article
  11. Article
  12. Genetics of human brain development.Nature reviews. Genetics · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kathryn H MorelliDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-3123-5369
Wenhao JinDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-7885-3527
Shashank ShatheDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0003-3013-4459
Assael A MadrigalDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-3311-5256
Krysten L JonesDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0001-9194-6245
Joshua L SchwartzDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-4263-2829
Tristan BridgesDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-4252-7965
Jasmine R MuellerDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0001-6236-8001
Archana ShankarDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0003-3499-4309
Isaac A ChaimDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0003-1787-046X
John W DayStanford University School of Medicine, Palo Alto, CA 94375, USA.ORCID 0000-0002-0086-9529
Gene W YeoDepartment of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-0799-6037
University of California San Diego · USPalo Alto University · US

Funding

UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
Single-cell approaches to deconvolution of disease-associated signalsU19MH107367 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MUOTRI, ALYSSON R. · 2015 to 2019
$15.0M
Functional RNA elements in the human genomeR01HG004659 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Kevin Daniel Corbett, Eugene Wei-Ming Yeo · 2008 to 2026
$12.4M
Single-Cell Transcriptomic and Epigenetics CoreP01AI132122 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, JOHN T · 2018 to 2022
$9.8M
A Comprehensive Functional Map of Human Protein-RNA InteractionsU41HG009889 · NHGRI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI GRAVELEY, BRENTON R. · 2018 to 2021
$9.4M
Therapeutic strategies for microsatellite expansion diseases using RNA-targeting CRISPR/CasR01NS103172 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MAURICE SCOTT SWANSON, Eugene Wei-Ming Yeo · 2017 to 2026
$5.6M
A comprehensive binding and functional map of human RNA-binding proteinsU24HG009889 · NHGRI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI GRAVELEY, BRENTON R., YEO, EUGENE WEI-MING · 2022 to 2025
$5.5M
Using single-cell RNA-seq to interrogate host immunity to pathogensR01AI123202 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, JOHN T, YEO, EUGENE WEI-MING · 2016 to 2020
$3.1M
Application of RNA-targeting Cas9 to Fuchs' dystrophyR01EY029166 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AFSHARI, NATALIE ADEL, YEO, EUGENE WEI-MING · 2018 to 2021
$1.4M
NovaSeq5000 High Throughput SequencerS10OD025052 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SEUMOIS, GREGORY · 2018 to 2018
$832k
Illumina NovaSeq 6000 Sequencing SystemS10OD026929 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEPSEN, KRISTEN LYNN · 2019 to 2019
$600k
Development of RNA-Directed Therapeutics for Myotonic Dystrophy Type 1 NeuropathologyF32NS112654 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MORELLI, KATHRYN H · 2019 to 2021
$161k
NEI NIH HHS R01 EY029166NHGRI NIH HHS R01 HG004659NHGRI NIH HHS U24 HG009889NHGRI NIH HHS U41 HG009889NIAID NIH HHS P01 AI132122NIAID NIH HHS R01 AI123202NIGMS NIH HHS K12 GM068524NIH HHS S10 OD025052NIH HHS S10 OD026929NIMH NIH HHS U19 MH107367NINDS NIH HHS F32 NS112654NINDS NIH HHS R01 NS103172
6 · The paper itself

Abstract

Myotonic dystrophy type 1 (DM1) is a multisystem, autosomal-dominant inherited disorder caused by CTG microsatellite repeat expansions (MREs) in the 3' untranslated region of the dystrophia myotonica-protein kinase (

Indexed as

Methyl-CpG-Binding Protein 2Myotonic DystrophyAdultCELF ProteinsHumansNerve Tissue ProteinsOrganoidsRNA-Binding ProteinsRNA SplicingTrinucleotide Repeat ExpansionCELF2 protein, humanCELF ProteinsMECP2 protein, humanMethyl-CpG-Binding Protein 2Nerve Tissue ProteinsRNA-Binding Proteins

Identifiers

PMID35767654
PMCPMC9645119
OpenAlexW4283701382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.